Payment overview · 2025
General Payments
$37.54
2 reported records · 2 companies
Healthcare provider profile · identity verified
Maria E Molina
Allopathic & Osteopathic Physicians|Internal Medicine · HIALEAH, FL · NPI 1750311700
Verified facts
What the public records show
CMS Open Payments records show Maria E Molina received $37.54 in general payments during 2025 across 2 reported records.
GlaxoSmithKline, LLC. accounted for 60.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Shingrix.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Shingrix by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $22.72 | 60.5% | 1 | 2025 |
| Phadia US Inc. | Unresolved — no canonical attribution shown | $14.82 | 39.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $37.54 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $22.72 | 1 | 2025 |
Source payment records
|
|||||
| ImmunoCAP Normalized: immunocap |
Device | Phadia US Inc. | $14.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| SHINGRIX shingrix |
2025 | Shingrix | 2024 | 41 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
41 | 28 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1663 | 466 |
| Losartan Potassium | Losartan Potassium | 1115 | 275 |
| Gabapentin | Gabapentin | 911 | 170 |
| Levothyroxine Sodium | Levothyroxine Sodium | 753 | 148 |
| Omeprazole | Omeprazole | 658 | 226 |
| Amlodipine Besylate | Amlodipine Besylate | 557 | 145 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 471 | 133 |
| Hydrochlorothiazide | Hydrochlorothiazide | 422 | 126 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 415 | 160 |
| Xarelto | Rivaroxaban | 409 | 53 |
| Furosemide | Furosemide | 396 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 391 | 122 |
| Lisinopril | Lisinopril | 381 | 100 |
| Sertraline Hcl | Sertraline Hcl | 349 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 341 | 84 |
| Fluticasone Propionate | Fluticasone Propionate | 316 | 106 |
| Alendronate Sodium | Alendronate Sodium | 309 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 308 | 93 |
| Metoprolol Tartrate | Metoprolol Tartrate | 286 | 66 |
| Famotidine | Famotidine | 277 | 93 |
| Mirtazapine | Mirtazapine | 267 | 84 |
| Metformin Hcl Er | Metformin Hcl | 265 | 73 |
| Metformin Hcl | Metformin Hcl | 262 | 77 |
| Dapagliflozin | Dapagliflozin Propanediol | 226 | 41 |
| Lansoprazole | Lansoprazole | 224 | 61 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 221 | 49 |
| Folic Acid | Folic Acid | 220 | 69 |
| Glipizide | Glipizide | 220 | 48 |
| Warfarin Sodium | Warfarin Sodium | 213 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 207 | 76 |
| Clopidogrel | Clopidogrel Bisulfate | 196 | 59 |
| Trazodone Hcl | Trazodone Hcl | 179 | 58 |
| Carvedilol | Carvedilol | 173 | 50 |
| Buspirone Hcl | Buspirone Hcl | 172 | 62 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 169 | 41 |
| Temazepam | Temazepam | 167 | 23 |
| Sildenafil Citrate | Sildenafil Citrate | 166 | 34 |
| Hydrocortisone | Hydrocortisone | 158 | 51 |
| Simvastatin | Simvastatin | 156 | 47 |
| Donepezil Hcl | Donepezil Hcl | 154 | 48 |
| Spironolactone | Spironolactone | 151 | 28 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 149 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 144 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 143 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 130 | 36 |
| Memantine Hcl | Memantine Hcl | 127 | 34 |
| Montelukast Sodium | Montelukast Sodium | 125 | 36 |
| Lactulose | Lactulose | 121 | 36 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 116 | 33 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 102 | 23 |
| Pregabalin | Pregabalin | 101 | 22 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 100 | 72 |
| Clonazepam | Clonazepam | 91 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 91 | 50 |
| Allopurinol | Allopurinol | 90 | 23 |
| Alprazolam | Alprazolam | 90 | 19 |
| Ibandronate Sodium | Ibandronate Sodium | 90 | 35 |
| Glipizide Er | Glipizide | 83 | 27 |
| Ipratropium Bromide | Ipratropium Bromide | 83 | 50 |
| Potassium Chloride | Potassium Chloride | 82 | 22 |
| Finasteride | Finasteride | 81 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 78 | 42 |
| Celecoxib | Celecoxib | 77 | 33 |
| Atenolol | Atenolol | 74 | 19 |
| Mupirocin | Mupirocin | 74 | 41 |
| Eliquis | Apixaban | 72 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 72 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 72 | 17 |
| Benzonatate | Benzonatate | 71 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 70 | 14 |
| Fenofibrate | Fenofibrate | 66 | 17 |
| Ketoconazole | Ketoconazole | 62 | 21 |
| Dutasteride | Dutasteride | 61 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 60 | 28 |
| Theophylline Er | Theophylline Anhydrous | 57 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 18 |
| Nifedipine Er | Nifedipine | 53 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 50 | 19 |
| Nystatin | Nystatin | 49 | 15 |
| Silver Sulfadiazine | Silver Sulfadiazine | 49 | 13 |
| Digoxin | Digoxin | 47 | suppressed |
| Methylprednisolone | Methylprednisolone | 47 | 35 |
| Cephalexin | Cephalexin | 46 | 43 |
| Nyamyc | Nystatin | 46 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 45 | suppressed |
| Azithromycin | Azithromycin | 44 | 43 |
| Glimepiride | Glimepiride | 44 | 12 |
| Meloxicam | Meloxicam | 44 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 42 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 41 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 41 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 33 |
| Prednisone | Prednisone | 38 | 23 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 37 | suppressed |
| Ibuprofen | Ibuprofen | 34 | 16 |
| Baclofen | Baclofen | 33 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 33 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 30 | 30 |
| Clonidine Hcl | Clonidine Hcl | 30 | suppressed |
| Dapagliflozin-Metformin Er | Dapaglifloz Propaned/Metformin | 29 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 29 | suppressed |
| Telmisartan | Telmisartan | 29 | suppressed |
| Hydroxyurea | Hydroxyurea | 27 | suppressed |
| Nateglinide | Nateglinide | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 25 | 12 |
| Pradaxa | Dabigatran Etexilate Mesylate | 25 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 25 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Comfort Ez Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Levetiracetam | Levetiracetam | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 21 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 23 | 16 |
| Trulicity | Dulaglutide | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Insulin Degludec Pen (U-200) | Insulin Degludec | 22 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 21 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 21 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 18 |
| Labetalol Hcl | Labetalol Hcl | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 20 | suppressed |
| Anastrozole | Anastrozole | 19 | suppressed |
| Irbesartan | Irbesartan | 19 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 19 | suppressed |
| Bumetanide | Bumetanide | 18 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 18 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 18 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | 15 |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 18 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 16 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 16 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Fluocinonide | Fluocinonide | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 11 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 14 | 14 |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Felodipine Er | Felodipine | 14 | suppressed |
| Jardiance | Empagliflozin | 14 | 11 |
| Lorazepam | Lorazepam | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | 12 |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Levoxyl | Levothyroxine Sodium | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $37.54 · 2 records | GlaxoSmithKline, LLC. | ImmunoCAP, SHINGRIX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Shingrix play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error